GW&K Investment Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1082917
BOSTON, MA
Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,847,874
+$7,645,007 QoQ
Shares Held
149,501
+27.3% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 94.3646238846303.ToString("F0")%
Shared 5.594573985632299.ToString("F0")%
None 0.04080212973739482.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. LGND ranks #11 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
623,048 | $101,880,808 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,393,875 | $90,086,140 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
962,643 | $71,485,868 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
371,098 | $70,156,076 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,618,686 | $58,790,674 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
779,349 | $58,521,315 | |
| 7 | VCEL |
Vericel Corp
|
1,616,855 | $52,014,225 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,214,901 | $41,100,100 |
All Filings in LGND
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,847,874 | 149,501 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,202,867 | 117,432 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,692,393 | 32,135 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,800,436 | 33,431 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,664,970 | 34,858 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,769,965 | 35,184 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,779,498 | 37,761 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,287,656 | 39,018 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,906,821 | 39,765 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,952,025 | 55,335 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,242,805 | 37,430 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,747,586 | 38,108 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,858,394 | 38,858 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,010,279 | 30,094 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,633,242 | 30,404 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,873,451 | 33,660 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,447,202 | 34,873 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,458,061 | 25,510 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||